Jack Kaye
Vermögen: 1 Mio $ am 31.07.2026
Vermögen: 1 Mio $ am 31.07.2026
Jack L.
Kaye is currently an Independent Director at Dyadic International, Inc. since 2015, an Independent Non-Executive Director at uniQure NV since 2016, a Director at DiaCarta, Inc. since 2022, and a Director at Tda Industries, Inc. since 2024.
Formerly, Mr. Kaye was an Independent Director at Keryx Biopharmaceuticals, Inc. from 2011 to 2016, a Director at Balboa Biosciences, Inc., an Independent Director at Tongli Pharmaceuticals (USA), Inc., and a Partner at Deloitte LLP (New York) from 1978 to 2006.
Education includes undergraduate studies at Baruch College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
UNIQURE N.V. 0.04% | 30.06.2026 | 25’996 ( 0.04% ) | 1 Mio $ | 31.07.2026 |
| 24.04.2026 | 81’201 ( 0.22% ) | 85 261 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| DYADIC INTERNATIONAL, INC. | Direktor/Vorstandsmitglied | 01.05.2015 |
| UNIQURE N.V. | Direktor/Vorstandsmitglied | 15.06.2016 |
DiaCarta, Inc.
DiaCarta, Inc. BiotechnologyHealth Technology Operates as a translational genomics and precision molecular diagnostics company | Direktor/Vorstandsmitglied | 07.04.2022 |
Tda Industries, Inc.
Tda Industries, Inc. Wholesale DistributorsDistribution Services Manufactures roofing, siding, and insulation materials | Direktor/Vorstandsmitglied | 01.02.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | Direktor/Vorstandsmitglied | 25.05.2016 |
| TONGLI PHARMACEUTICALS (USA), INC. | Direktor/Vorstandsmitglied | 19.06.2009 |
Deloitte LLP (New York)
Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax preparation and financial advisory services | Corporate Officer/Principal | 01.05.2006 |
Balboa Biosciences, Inc.
Balboa Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics for central nervous system disorders | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Tda Industries, Inc.
Tda Industries, Inc. Wholesale DistributorsDistribution Services Manufactures roofing, siding, and insulation materials | Distribution Services |
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Dyadic International, Inc.
Dyadic International, Inc. Medical/Nursing ServicesHealth Services Manufactures genes and other biological products | Health Services |
Deloitte LLP (New York)
Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax preparation and financial advisory services | Commercial Services |
Baruch College
Baruch College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Balboa Biosciences, Inc.
Balboa Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics for central nervous system disorders | Health Technology |
Tongli Pharmaceuticals (USA), Inc.
Tongli Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical and health care products | Health Technology |
uniQure NV
uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products | Health Technology |
DiaCarta, Inc.
DiaCarta, Inc. BiotechnologyHealth Technology Operates as a translational genomics and precision molecular diagnostics company | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen